---
title: "Anagliptin - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db12417-mesh-d003924-1.html
toc: false 
---


Path ID: `DB12417_MESH_D003924_1`
{% include image.html url="images/db12417-mesh-d003924-1.png" file="db12417-mesh-d003924-1.png" alt="db12417-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C583175">MESH:C583175 </a> | anagliptin | Drug |
| <a href="https://identifiers.org/UniProt:P27487">UniProt:P27487 </a> | Dipeptidyl peptidase 4 | Protein |
| <a href="https://identifiers.org/CHEBI:80270">CHEBI:80270 </a> | Glucagon-like peptide 1 | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0030073">GO:0030073 </a> | insulin secretion | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070091">GO:0070091 </a> | glucagon secretion | BiologicalProcess |
| <a href="https://identifiers.org/HP:0003074">HP:0003074 </a> | Hyperglycemia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003924">MESH:D003924 </a> | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Anagliptin | DECREASES ACTIVITY OF | Dipeptidyl Peptidase 4 |
| Dipeptidyl Peptidase 4 | DECREASES ABUNDANCE OF | Glucagon-Like Peptide 1 |
| Glucagon-Like Peptide 1 | POSITIVELY REGULATES | Insulin Secretion |
| Glucagon-Like Peptide 1 | NEGATIVELY REGULATES | Glucagon Secretion |
| Insulin Secretion | NEGATIVELY REGULATES | Hyperglycemia |
| Glucagon Secretion | POSITIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | MANIFESTATION OF | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB12417](https://go.drugbank.com/drugs/DB12417)
  - [https://en.wikipedia.org/wiki/Anagliptin](https://en.wikipedia.org/wiki/Anagliptin)
  - [https://en.wikipedia.org/wiki/Type_2_diabetes](https://en.wikipedia.org/wiki/Type_2_diabetes)
